Melanoma

Immunotherapeutic targeting of HSP90 client proteins in BRAF-inhibitor resistant melanoma
Ronald J Fecek, Simeng Wang, Walter J Storkus

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P432; DOI: 10.1186/2051-1426-3-S2-P432
Study and characterization of mutated antigen specific T cells isolated from fresh tumor and peripheral lymphocytes in cancer patients
Cyrille Cohen, Jared J Gartner, Miryam Horovitz-Fried, Katerina Shamalov, Kasia Trebska-Mcgowan, Valery Bliskovsky, Maria R Parkhurst, Chen Ankri, Todd D Prickett, Jessica Crystal, Yong Li, Mona El-Gamil, Steven A Rosenberg, Paul F Robbins

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P7; DOI: 10.1186/2051-1426-3-S2-P7
Vaccination with long NY-ESO-1 79-108 peptide and CpG-B leads to robust activation of CD4 and CD8 T cell responses in stage III/IV melanoma patients, and a new HLA-DR7 epitope
Petra Baumgartner, Carla Costa Nunes, Amélie Cachot, Hélène Maby-El Hajjami, Laurène Cagnon, Marion Braun, Laurent Derré, Jean-Paul Rivals, Donata Rimoldi, Emanuela Romano, Olivier Michielin, Pedro Romero, Camilla Jandus, Daniel E Speiser

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P437; DOI: 10.1186/2051-1426-3-S2-P437
Electrotransfer of IL-15/IL-15Rα complex for the treatment of established melanoma
Shawna Shirley, Cathryn Lundberg, Niculina Burcus, Richard Heller

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P244; DOI: 10.1186/2051-1426-3-S2-P244
Tissue resident memory T cells create genetically distinct immune microenvironments within melanoma metastasis
Kavita Dhodapkar, Noffar Bar, Chandra Sekhar Boddupalli, Krishna Kadaveru, Zifeng Mai, Yanhong Deng, Mario Sznol, Madhav Dhodapkar

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) O15; DOI: 10.1186/2051-1426-3-S2-O15
Phenotype, function and T cell receptor repertoire of tumor-infiltrating lymphocytes in patients with pancreatic ductal adenocarcinoma
Isabel Poschke, Michael Flossdorf, Marta Faryna, Frank Bergmann, Jessica Hassel, Oliver Strobel, Rienk Offringa

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P44; DOI: 10.1186/2051-1426-3-S2-P44
Density of immunogenic antigens does not explain presence or absence of the T cell-inflamed tumor microenvironment in metastatic melanoma
Yuanyuan Zha, Stefani Spranger, Kyle M Hernandez, Yan Li, Riyue Bao, Peter Alexieff, Jorge Andrade, Jason J Luke, Thomas F Gajewski

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P425; DOI: 10.1186/2051-1426-3-S2-P425
High frequency CD8+PD-1+ TCR clonotypes isolated from fresh melanomas display anti-tumor activity
Pasetto Anna, Alena Gros, Paul F Robbins, Todd D Prickett, Drew C Deniger, Rodrigo Matus-Nicodemus, Maria R Parkhurst, Jessica S Crystal, Kasia Trebska-Mcgowan, Steven A Rosenberg

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P42; DOI: 10.1186/2051-1426-3-S2-P42
Functional antigen presenting cells generated from human dendritic cells (DC) derived induced pluripotent stem cell lines
Arvind Chhabra

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P206; DOI: 10.1186/2051-1426-3-S2-P206
Safety data of Montanide ISA 51 VG and Montanide ISA 720 VG, two adjuvants dedicated to human therapeutic vaccines
Stephane Ascarateil, Aude Puget, Marie-Eve Koziol

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P428; DOI: 10.1186/2051-1426-3-S2-P428

Main menu

Melanoma

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Melanoma

Pages